Home/Filings/4/0001140361-17-046227
4//SEC Filing

THOMPSON PHILLANDAS T. 4

Accession 0001140361-17-046227

CIK 0001012477other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 4:08 PM ET

Size

13.7 KB

Accession

0001140361-17-046227

Insider Transaction Report

Form 4
Period: 2017-12-12
Transactions
  • Award

    Stock Option (right to buy)

    2017-12-12$8.95/sh+80,000$716,00080,000 total
    Exercise: $8.95Exp: 2027-12-12ADSs (80,000 underlying)
  • Award

    ADSs

    2017-12-12+18,00081,000 total
Holdings
  • Stock Option (right to buy)

    Exercise: $16.30Exp: 2024-12-11ADSs (95,000 underlying)
    95,000
  • Stock Option (right to buy)

    Exercise: $7.36Exp: 2023-12-12ADSs (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $10.40Exp: 2026-12-14ADSs (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $14.35Exp: 2025-12-10ADSs (100,000 underlying)
    100,000
Footnotes (7)
  • [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
  • [F2]Includes (a) 10,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/11/2014, all of which will be issued to the reporting person on the fourth anniversary of the grant date; (b) 20,000 restricted ADSs granted under the issuer's "Free Share" award program on 8/10/2016, all of which will be issued to the reporting person on the second anniversary of the grant date; (c) 18,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/14/2016, all of which will be issued to the reporting person on the second anniversary of the grant date; and (d) 18,000 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, under which 12,000 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 6,000 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until th
  • [F3]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2013 grant date.
  • [F4]Options become exercisable as to 23,750 ADSs on each of the first four anniversaries after the 12/11/2014 grant date.
  • [F5]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.
  • [F6]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
  • [F7]Options become exercisable as to 20,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.

Documents

1 file

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001661781

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:08 PM ET
Size
13.7 KB